Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials

INTRODUCTION: The present study aims to evaluate the risk of pancreatic cancer with incretin-based therapy among patients with type 2 diabetes mellitus (T2DM). METHODS: We searched EMBASE, MEDLINE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for eligible studies publish...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Han, Zhou, Xiaoying, Chen, Tao, Liu, Bingtuan, Jin, Wujuan, Gu, Huiyuan, Hong, Tianyuan, Zhang, Guoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118236/
https://www.ncbi.nlm.nih.gov/pubmed/27655330
http://dx.doi.org/10.1007/s13300-016-0198-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118236/
https://www.ncbi.nlm.nih.gov/pubmed/27655330
http://dx.doi.org/10.1007/s13300-016-0198-3

Ejemplares similares